Table 3.
Determination (delta, Δ) of changes in some variables before and after the study
| Variables |
Nano-curcumin
N=35 (Δ=after- before) |
Placebo
N=35 (Δ=after- before) |
p value |
|---|---|---|---|
| ΔFBG | -17.12±40.38 | -24.88±53.94 | 0.657 |
| ΔHbA1c | -0.91±1.11 | 0.33±1.48 | 0.013 |
| ΔeAG | -21.88±25.42 | 9.56±42.71 | 0.015 |
| ΔTC | -15.45±44.75 | -13.11±36.74 | 0.889 |
| ΔLDL-C | -16.41±30.93 | -8.95±25.51 | 0.046 |
| ΔHDL-C | 1.83±13.11 | 2.11±6.91 | 0.952 |
| ΔTG | -6.7±67.52 | -15.33±37.39 | 0.772 |
| ΔBMI | -1.34±1.88 | 0.22±1.31 | 0.001 |
Δ=after- before for ech value, BMI: Body Mass Index, FBG: Fasting blood glucose, TC: total cholesterol, HDL-C: High density lipoprotein- cholesterol, LDL-C: Low density lipoprotein- cholesterol, TG: triglyceride, IQR: Interquartile Range.eAG: estimated Average Glucose =(28.7HbA1CHbA1c)-46.7